Citation Impact
Citing Papers
Prospective Study of Obstructive Sleep Apnea and Incident Coronary Heart Disease and Heart Failure
2010 Standout
Adiponectin accumulates in myocardial tissue that has been damaged by ischemia-reperfusion injury via leakage from the vascular compartment
2007
Physiological, Pharmacological, and Nutritional Regulation of Circulating Adiponectin Concentrations in Humans
2008
Obesity, adiponectin and vascular inflammatory disease
2003
Thiazolidinediones
2004 Standout
Noninvasive imaging of the renal arteries
2001
Abdominal obesity and metabolic syndrome
2006 StandoutNature
Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study
2009 Standout
Adiponectin protects against cerebral ischemia–reperfusion injury through anti-inflammatory action
2009 StandoutNobel
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
Association of Plasma Adiponectin Levels with Oxidative Stress in Hemodialysis Patients
2007
Gender-specific association of adiponectin as a predictor of progression of chronic kidney disease: The Mild to Moderate Kidney Disease Study
2007
Increased oxidative stress in obesity and its impact on metabolic syndrome
2004 Standout
Close association of hypoadiponectinemia with arteriosclerosis obliterans and ischemic heart disease
2005
Adiponectin and Cardiovascular Outcomes among Hemodialysis Patients
2012
Mechanisms linking obesity with cardiovascular disease
2006 StandoutNature
PROGRESS IN UREMIC TOXIN RESEARCH: Adiponectin in Patients with Chronic Kidney Disease
2009
Reduced gene expression of adiponectin in fat tissue from patients with end-stage renal disease
2004
The metabolic syndrome
2010 Standout
Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes
2008 Standout
Serum visfatin concentration and endothelial dysfunction in chronic kidney disease
2007
Cellular pathophysiology of ischemic acute kidney injury
2011 Standout
Exercise Standards for Testing and Training
2013 Standout
Impact of adiposity and plasma adipocytokines on diabetic angiopathies in Japanese Type 2 diabetic subjects
2004
Plasma Adiponectin Levels and Risk of Myocardial Infarction in Men
2004 Standout
The Adipose Tissue as an Endocrine Organ – A Nephrologists’ Perspective
2006
Plasma adiponectin concentration before and after successful kidney transplantation
2003
Abdominal Obesity and All-Cause and Cardiovascular Mortality in End-Stage Renal Disease
2009
Adiponectin and Cardiovascular Remodeling in End-Stage Renal Disease and Co-Morbid Diabetes Mellitus
2006
Serum adiponectin and markers of endothelial injury in hemodialysis patients with arteriosclerosis obliterans
2008
Ageing and plasma adiponectin concentration in apparently healthy males and females
2004
Changes in adiponectin and the risk of sudden death, stroke, myocardial infarction, and mortality in hemodialysis patients
2009
The Diagnostic Utility of Cardiac Biomarkers in Dialysis Patients
2012
Adiponectin protects against the development of systolic dysfunction following myocardial infarction
2007
Plasma adiponectin levels and clinical outcomes among haemodialysis patients
2008
Sympathetic hyperactivity in chronic kidney disease: Pathogenesis, clinical relevance, and treatment
2004
Dietary acid reduction with fruits and vegetables or bicarbonate attenuates kidney injury in patients with a moderately reduced glomerular filtration rate due to hypertensive nephropathy
2011
Inflammation, stress, and diabetes
2005 Standout
Fibromuscular Dysplasia
2004 Standout
The role of the novel adipocyte-derived hormone adiponectin in human disease
2003
Noradrenaline and extracellular nucleotide cotransmission involves activation of vasoconstrictive P2X1,3‐ and P2Y6‐like receptors in mouse perfused kidney
2005
The effect of renal transplantation on adiponectin and its isoforms and receptors
2007
Assessing Kidney Function — Measured and Estimated Glomerular Filtration Rate
2006 Standout
Obesity
2005 Standout
Renal Insulin Resistance Syndrome, Adiponectin and Cardiovascular Events in Patients with Kidney Disease
2005
Significance of Acute versus Chronic Troponin T Elevation in Dialysis Patients
2004
Adiponectin in renal disease: Relationship to phenotype and genetic variation in the gene encoding adiponectin
2003
Adiponectin as an anti-inflammatory factor
2007
Endothelial activation and circulating markers of endothelial activation in kidney disease
2010
Adipokines in inflammation and metabolic disease
2011 Standout
The metabolic syndrome
2005 Standout
Chronic hypoxia increases blood pressure and noradrenaline spillover in healthy humans
2003
Serum adiponectin complexes and cardiovascular risk in children with chronic kidney disease
2011
Adiponectin Levels and Risk of Type 2 Diabetes
2009 Standout
Role of Adiponectin in Preventing Vascular Stenosis
2002
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes
2005 StandoutNature
The emerging pleiotrophic role of adipokines in the uremic phenotype
2009
Adiponectin regulates albuminuria and podocyte function in mice
2008
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
The metabolic syndrome and adipocytokines
2006
Reciprocal Association of Plasma Adiponectin and Serum C-Reactive Protein Concentration in Haemodialysis Patients with End-Stage Kidney Disease – A Follow-Up Study
2005
Adiponectin Is Associated with Brain Natriuretic Peptide and Left Ventricular Hypertrophy in Hemodialysis Patients with Type 2 Diabetes Mellitus
2007
Diabetes Mellitus, Aortic Stiffness, and Cardiovascular Mortality in End-Stage Renal Disease
2001
Low fat adiponectin expression is associated with oxidative stress in nondiabetic humans with chronic kidney disease—impact on plasma adiponectin concentration
2007
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
Type 1 diabetes
2013 Standout
Sympathetic Activation in Chronic Renal Failure
2008
Sepsis-Associated Myocardial Dysfunction
2006
Differential Effect of Baseline Adiponectin on All-Cause Mortality in Hemodialysis Patients Depending on Initial Body Mass Index. Long-Term Follow-Up Data of 4.5 Years
2012
Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex
2003
The metabolic syndrome—a new worldwide definition
2005 Standout
Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences
2003 Standout
Up-regulation of adiponectin, its isoforms and receptors in end-stage kidney disease
2006
The role of fat topology in the risk of disease
2008
Resistin Serum Levels Are Increased but Not Correlated with Insulin Resistance in Chronic Hemodialysis Patients
2005
Therapy Insight: adipocytokines in metabolic syndrome and related cardiovascular disease
2006
Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications
2005
Increment and impairment of adiponectin in renal failure
2009
Adiponectin and Mortality in Patients with Chronic Kidney Disease
2006
Asymmetric Dimethylarginine: A Cardiovascular Risk Factor and a Uremic Toxin Coming of Age?
2005
Renal extraction of circulating adiponectin in patients with renovascular hypertension
2007
Total and high molecular weight adiponectin concentrations in plasma of patients with end‐stage renal disease before and after peritoneal dialysis
2008
Adiponectin Is Related to Carotid Artery Plaque and a Predictor of Cardiovascular Outcome in a Cohort of Non-Diabetic Peritoneal Dialysis Patients
2008
Chronic Kidney Disease
2016 Standout
Adipocytokines: mediators linking adipose tissue, inflammation and immunity
2006 Standout
Obesity and the Metabolic Syndrome in Children and Adolescents
2004 Standout
Adipose Tissue as an Endocrine Organ
2004 Standout
Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters
2009 Standout
Leptin and Coronary Heart Disease
2009
Prediction of Cardiovascular Events and All-Cause Mortality With Arterial Stiffness
2010 Standout
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome
2006 Standout
Chronic Kidney Disease Diagnosis and Management
2019 Standout
Reciprocal Relationships Between Insulin Resistance and Endothelial Dysfunction
2006 Standout
Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss
2005 Standout
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Adiponectin as a Biomarker of the Metabolic Syndrome
2004
Plasma Adiponectin Is an Independent Predictor of Type 2 Diabetes in Asian Indians
2003
Sleep Apnea and Cardiovascular Disease
2008
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial
2010 Standout
O2-regulated gene expression: transcriptional control of cardiorespiratory physiology by HIF-1
2004 StandoutNobel
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
Adiponectin and Coronary Heart Disease
2006
Association of Hypoadiponectinemia With Coronary Artery Disease in Men
2003
Sympathetic Nerve Activity in End-Stage Renal Disease
2002
Sleep Apnea and Cardiovascular Disease
2008
Plasma Adiponectin Levels and Five-Year Survival After First-Ever Ischemic Stroke
2005
American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death
2008
Prognostic Value of Cardiac Troponin in Patients With Chronic Kidney Disease Without Suspected Acute Coronary Syndrome
2014
Association Between Adiponectin and Mediators of Inflammation in Obese Women
2003
Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2
2012 StandoutNobel
Adiponectin and Renal Function, and Implication as a Risk of Cardiovascular Disease
2006
Low Plasma Adiponectin Levels Predict Progression of Coronary Artery Calcification
2005
Modulation of Circulating and Adipose Tissue Adiponectin Levels by Antidiabetic Therapy
2003
Adiponectin: a key adipocytokine in metabolic syndrome
2006
Low Resistin Level is Associated with Poor Hospitalization-Free Survival in Hemodialysis Patients
2012
Exacerbation of Albuminuria and Renal Fibrosis in Subtotal Renal Ablation Model of Adiponectin-Knockout Mice
2007
Type 1 Diabetes and Coronary Artery Disease
2006
K/DOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients
2005
Inflammatory Mechanisms in Obesity
2011 Standout
Cystatin C Concentration as a Risk Factor for Heart Failure in Older Adults
2005
Mechanisms of Diabetic Complications
2013 Standout
Right Ventricular Function in Cardiovascular Disease, Part I
2008 Standout
Adiponectin: More Than Just Another Fat Cell Hormone?
2003
Determinants of Serum High Molecular Weight (HMW) Adiponectin Levels in Patients with Coronary Artery Disease: Associations with Cardio-renal-anemia Syndrome
2011
Serum Adiponectin and Progression of Diabetic Nephropathy in Patients With Type 1 Diabetes
2008
Androgens Decrease Plasma Adiponectin, an Insulin-Sensitizing Adipocyte-Derived Protein
2002
Abdominal Visceral and Subcutaneous Adipose Tissue Compartments
2007 Standout
Leptin and Cardiovascular Disease
2008
Adiponectin Reduces Atherosclerosis in Apolipoprotein E-Deficient Mice
2002
The Metabolic Syndrome: Time for a Critical Appraisal
2005 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Adiponectin and Metabolic Syndrome
2003
Adiponectin Specifically Increased Tissue Inhibitor of Metalloproteinase-1 Through Interleukin-10 Expression in Human Macrophages
2004
Works of Francesco Rapisarda being referenced
Plasma Norepinephrine Predicts Survival and Incident Cardiovascular Events in Patients With End-Stage Renal Disease
2002
Adiponectin, Metabolic Risk Factors, and Cardiovascular Events among Patients with End-Stage Renal Disease
2002
Diagnosis of Renovascular Disease by Extra- and Intrarenal Doppler Parameters
1998
Troponin is related to left ventricular mass and predicts all-cause and cardiovascular mortality in hemodialysis patients
2002
Fibrinogen, mortality and incident cardiovascular complications in end‐stage renal failure
2003
Circulating E‐selectin as a risk marker in patients with end‐stage renal disease
2007
Diagnostic value of troponin T for alterations in left ventricular mass and function in dialysis patients
2002
Italian Audit on Therapy of Hypertension in Chronic Kidney Disease: The TABLE-CKD Study
2005
Smoking, blood pressure and serum albumin are major determinants of carotid atherosclerosis in dialysis patients. CREED Investigators. Cardiovascular Risk Extended Evaluation in Dialysis patients.
1999